Cargando…
Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
Randomized controlled trials (RCTs) are preferred by payers for health technology assessments and coverage decisions. However, the inclusion of a highly selective patient population and the rigorously controlled conditions in RCTs may not be reflective of real-world clinical practice. Real-world evi...
Autores principales: | Roberts, Melissa H., Ferguson, Gary T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7895868/ https://www.ncbi.nlm.nih.gov/pubmed/32557235 http://dx.doi.org/10.1007/s41669-020-00221-y |
Ejemplares similares
-
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies
por: Howdon, Daniel, et al.
Publicado: (2022) -
Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action
por: Farghaly, Mohamed Nasr Mahmoud Hassan, et al.
Publicado: (2022) -
Biosimilars: How Can Payers Get Long-Term Savings?
por: Mestre-Ferrandiz, Jorge, et al.
Publicado: (2016) -
Payer perceptions of the use of real-world evidence in oncology-based decision making
por: Brixner, Diana, et al.
Publicado: (2021) -
Bridging the gap between reference and real transcriptomes
por: Morillon, Antonin, et al.
Publicado: (2019)